Annual CFI
$72.41 M
+$104.97 M+322.38%
December 31, 2023
Summary
- As of February 8, 2025, CARM annual cash flow from investing activities is $72.41 million, with the most recent change of +$104.97 million (+322.38%) on December 31, 2023.
- During the last 3 years, CARM annual CFI has risen by +$72.85 million (+16556.36%).
- CARM annual CFI is now at all-time high.
Performance
CARM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
+$106.00 K+100.00%
September 30, 2024
Summary
- As of February 8, 2025, CARM quarterly cash flow from investing activities is $0.00, with the most recent change of +$106.00 thousand (+100.00%) on September 30, 2024.
- Over the past year, CARM quarterly CFI has dropped by -$29.81 million (-100.00%).
- CARM quarterly CFI is now -100.00% below its all-time high of $35.75 million, reached on June 30, 2023.
Performance
CARM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$10.32 M
-$29.81 M-74.29%
September 30, 2024
Summary
- As of February 8, 2025, CARM TTM cash flow from investing activities is $10.32 million, with the most recent change of -$29.81 million (-74.29%) on September 30, 2024.
- Over the past year, CARM TTM CFI has dropped by -$65.46 million (-86.39%).
- CARM TTM CFI is now -86.42% below its all-time high of $75.99 million, reached on March 31, 2024.
Performance
CARM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CARM Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +322.4% | -100.0% | -86.4% |
| 3 y3 years | +10000.0% | -100.0% | +131.7% |
| 5 y5 years | +10000.0% | -100.0% | +131.7% |
CARM Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +322.4% | -100.0% | +100.0% | -86.4% | +116.1% |
| 5 y | 5-year | at high | +322.4% | -100.0% | +100.0% | -86.4% | +116.1% |
| alltime | all time | at high | +322.4% | -100.0% | +100.0% | -86.4% | +116.1% |
Carisma Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $10.32 M(-74.3%) |
| Jun 2024 | - | -$106.00 K(+523.5%) | $40.13 M(-47.2%) |
| Mar 2024 | - | -$17.00 K(-100.2%) | $75.99 M(+4.9%) |
| Dec 2023 | $72.41 M | $10.44 M(-65.0%) | $72.41 M(-4.4%) |
| Sep 2023 | - | $29.81 M(-16.6%) | $75.78 M(+73.3%) |
| Jun 2023 | - | $35.75 M(-1094.5%) | $43.74 M(+55.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$3.60 M(-126.0%) | $28.10 M(-186.3%) |
| Dec 2022 | -$32.56 M(+1640.2%) | $13.81 M(-719.8%) | -$32.56 M(-29.8%) |
| Sep 2022 | - | -$2.23 M(-111.1%) | -$46.37 M(+5.0%) |
| Jun 2022 | - | $20.11 M(-131.3%) | -$44.14 M(-31.3%) |
| Mar 2022 | - | -$64.25 M | -$64.25 M |
| Dec 2021 | -$1.87 M(+325.2%) | - | - |
| Dec 2020 | -$440.00 K | - | - |
FAQ
- What is Carisma Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Carisma Therapeutics?
- What is Carisma Therapeutics annual CFI year-on-year change?
- What is Carisma Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Carisma Therapeutics?
- What is Carisma Therapeutics quarterly CFI year-on-year change?
- What is Carisma Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Carisma Therapeutics?
- What is Carisma Therapeutics TTM CFI year-on-year change?
What is Carisma Therapeutics annual cash flow from investing activities?
The current annual CFI of CARM is $72.41 M
What is the all time high annual CFI for Carisma Therapeutics?
Carisma Therapeutics all-time high annual cash flow from investing activities is $72.41 M
What is Carisma Therapeutics annual CFI year-on-year change?
Over the past year, CARM annual cash flow from investing activities has changed by +$104.97 M (+322.38%)
What is Carisma Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CARM is $0.00
What is the all time high quarterly CFI for Carisma Therapeutics?
Carisma Therapeutics all-time high quarterly cash flow from investing activities is $35.75 M
What is Carisma Therapeutics quarterly CFI year-on-year change?
Over the past year, CARM quarterly cash flow from investing activities has changed by -$29.81 M (-100.00%)
What is Carisma Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CARM is $10.32 M
What is the all time high TTM CFI for Carisma Therapeutics?
Carisma Therapeutics all-time high TTM cash flow from investing activities is $75.99 M
What is Carisma Therapeutics TTM CFI year-on-year change?
Over the past year, CARM TTM cash flow from investing activities has changed by -$65.46 M (-86.39%)